Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan. The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123

Reference

Title
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan
Volume & Issue
Volume 26, Issue 1
Pages
111-123

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  
  • Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.  
  • Stroke risk reduction from thrombin inhibitor in AFib patients
    A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared…  
  • While treatment with antihypertensives has already generated a benefit-to-cost ratio of at least 6:1 (6:1 for women and 10:1 for men), more effective use of antihypertensive medication would have an…  
  • Development and widespread use of left ventricular assist devices could result in a 50% decrease in heart failure-related hospitalizations.